US Patent Issued to Bluefin BioMedicine on Sept. 30 for "Anti-VTCN1 antibodies and antibody drug conjugates" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,427,163, issued on Sept. 30, was assigned to Bluefin BioMedicine Inc (Beverly, Mass.).

"Anti-VTCN1 antibodies and antibody drug conjugates" was invented by Ailan Guo (Lexington, Mass.), Svetlana Popova (Andover, Mass.), Scott Michael Lonning (Westford, Mass.) and Jason G. Beaudet (Beverly, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are anti-V-set domain containing T cell activation inhibitor 1 (VTCN1) antibodies and antibody drug conjugates (ADCs), including compositions and methods of using said antibodies and ADCs."

The patent was filed on Jan. 29, 2024, under Application No. 18/425,844.

*For further information, includin...